Hims & Hers health PAO Becklund Irene sells shares worth $63,402 By Investing.com
Hims & Hers health PAO Becklund Irene sells shares worth $63,402…
25,991$
-7,14%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims & Hers CFO Okupe Oluyemi sells $338,833 in stock By Investing.com
Hims & Hers CFO Okupe Oluyemi sells $338,833 in stock…
Hims & Hers health executive sells $63,402 in stock By Investing.com
Hims & Hers health executive sells $63,402 in stock…
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings
Hims & Hers Health (NYSE:HIMS) recently experienced a 5% price increase over the past quarter, marked by significant corporate events.…
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings
Hims & Hers Health (NYSE:HIMS) recently experienced a 5% price increase over the past quarter, marked by significant corporate events.…
Hims & Hers : Telehealths billion-dollar surge
Hims & Hers is a telehealth platform specializing in sexual health, dermatology, mental health, and weight loss. Founded by Andrew…
Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner
…
Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner (NYSE:LLY)
Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges. Find out who is…
DTC obesity med market heats up: Eli Lilly taps knownwell, Hims & Hers adds new weight loss meds to platform
Hims & Hers is expanding access to Eli Lillys branded weight loss drug Zepbound and diabetes drug Mounjaro as well…
Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
Hims & Hers Health Inc. (HIMS) is facing increased skepticism from investors and analysts over the sustainability concerns of its…
Zepbound Now Available Through Hims AND Hers
WEDNESDAY, April 2, 2025 (HealthDay News) -- The telehealth company Hims & Hers Health is expanding its weight-loss offerings by…
Why Hims & Hers Health Stock Couldnt Beat the Market Today
Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldnt top the benchmark…
Hims & Hers Stock Rises 5% After Adding Zepbound And Mounjaro To Weight Loss Platform
Hims & Hers Health shares rose 5% Tuesday after announcing it will offer Eli Lilly’s Zepbound and Mounjaro through its…
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
The digital healthcare platform announced Tuesday that it has added Zepbound and generic liraglutide to its platform…
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update…
Zepbound now available through Hims & Hers
(HealthDay News) — The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to…
Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Why Hims & Hers Health Stock Couldnt Beat the Market Today
Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldnt top the benchmark…
‘Too Hot to Handle,’ Analyst Warning on Hims & Hers Health Stock (HIMS)
Telehealth platform Hims Hers Health, Inc. ($HIMS), which connects consumers to healthcare professionals, is at a crossroads. With sales…
Eli Lilly says it has “no affiliation” with Hims & Hers after market confusion
Hims & Hers investors are clearly antsy about where the company’s weight-loss business is going and Tuesday’s announcement was supposed…
Zepbound Now Available Through Hims & Hers
WEDNESDAY, April 2, 2025 (HealthDay News) -- The telehealth company Hims & Hers Health is expanding its weight-loss offerings by…
Zepbound Now Available Through Hims & Hers
By I. Edwards HealthDay Reporter WEDNESDAY, April 2, 2025 (HealthDay News) -- The telehealth company Hims & Hers Health is…
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we…
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this…
Hims & Hers Health Aktie: Zepbound-Verkauf bringt kaum Deckungsbeiträge
Charlotte (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse der Bank of America (BofA):
Die BofA bestätigt ihre "underperform"-Einschätzung für die Aktie von…
Hims & Hers (HIMS) Stock Climbs as Weight Loss Arsenal Grows with Zepbound Addition
Hims & Hers adds Eli Lillys Zepbound to its platform at $1,899 monthly, boosting its weight loss portfolio…
Hims & Hers to sell Lilly’s weight-loss drug on its telehealth platform
The company said it will expand its weight-loss offerings with branded versions of Lillys tirzepatide.…
Sell Rating for Hims & Hers Health Due to High Pricing and Limited Market Penetration of New Offerings
Daniel Grosslight, an analyst from Citi, maintained the Sell rating on Hims & Hers Health (HIMS – Research Report). The…
Eli Lilly Says It Has No Affiliation With Hims & Hers Regarding Zepbound
Eli Lilly said Tuesday it doesnt have any affiliation with Hims & Hers Health , adding that its weight-loss…
Hims & Hers beginnt mit dem Verkauf von Eli Lilly-Medikamenten zur Gewichtsreduktion
Die FDA hat dem Unternehmen vor kurzem die befristete Erlaubnis zur Herstellung ähnlicher GLP-1-Medikamente entzogen, was einen großen Teil der…
Truist maintains Hims & Hers stock hold rating, $39 target By Investing.com
Truist maintains Hims & Hers stock hold rating, $39 target…
Märkte am Morgen: Zittern vor Trump-Zöllen; Thyssen, LVMH, CoreWeave, Hims & Hers, Ralph Lauren, Tesla
Der DAX hat gestern kräftig zugelegt und den Handelstag bei 22.539 Punkten beendet. Die Vorgaben aus Übersee sind größtenteils positiv.…
Eli Lilly says company has no affiliation with Hims & Hers
In a statement on its website, Eli Lilly and Company (LLY) said it has no affiliation with hims hers…
Eli Lilly Has No Affiliation With Hims & Hers
Eli Lilly and Co:
* ELI LILLY:…
Hims & Hers health chief legal officer sells $89,863 in stock By Investing.com
Hims & Hers health chief legal officer sells $89,863 in stock…
Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback
Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to discuss some of the top stories of the trading day,…
Why Hims & Hers Health Stock Soared Tuesday
Shares of Hims & Hers Health (NYSE: HIMS) surged on Tuesday, closing the session up 5.25% after having been up…
Hims & Hers Health Stock Jumped Tuesday Afternoon: What Happened? - Hims & Hers Health (NYSE:HIMS)
Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer…
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.5% in the afternoon session after the company revealed it…
Hims & Hers shares rise as company adds new weight-loss medications to platform
Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide to its platform.…
BofA maintains Hims & Hers stock underperform, $22 target By Investing.com
BofA maintains Hims & Hers stock underperform, $22 target…
Eli Lilly weight loss therapy added to Hims & Hers platform (update)
Shares of Hims & Hers Health (NYSE:HIMS) traded higher on Tuesday after the telehealth company announced the addition of branded…